Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    PRICKLE1
Show Display Options
Rank Status Study
1 Recruiting Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Abraxane;   Drug: Gemcitabine

Indicates status has not been verified in more than two years